Ophthalmic suspension containing diflupredonate

Details Ophthalmic suspension containing diflupredonate Ophthalmic suspension containing diflupredonate

1994-12-20

1996-09-17

Cintins, Marianne M.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

A61K 3156

Patent

active

055568483

ABSTRACT:
An ophthalmic suspension comprising difluprednate as an active ingredient. The ophthalmic suspension of the present invention shows superior antiinflammatory action and antiallergic action by local administration. Accordingly, the suspension of the present invention is useful for the treatment and prevention of disorders of the eye, such as allergic conjunctivitis, vernal conjunctivitis, blepharitis marginalis, catarrhal conjunctivitis and uveitis.

REFERENCES:
patent: 3780177 (1973-12-01), Ercoli et al.
patent: 3784692 (1974-01-01), Ercoli et al.
patent: 4304765 (1981-12-01), Shell et al.
patent: 4478818 (1984-10-01), Shell et al.
patent: 5401510 (1995-03-01), Robertson et al.
patent: 5407926 (1995-04-01), Clark
patent: 5446070 (1995-08-01), Mandelli
Mitsubishi Chemical, Chemical Abstracts, vol. 118, No. 24 14 Jun. 1993 Abstract No. 240992 JP-A-05043465.
Mitsubishi Petroch, KK, Database WPI, Week 8636, Derwent Publications Ltd. London GB AN86-236771 (36) JP-A-61 167 614, 1991.

Affiliated with

Also associated with

Rating

Ophthalmic suspension containing diflupredonate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ophthalmic suspension containing diflupredonate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ophthalmic suspension containing diflupredonate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-413177